336 related articles for article (PubMed ID: 27450485)
21. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation.
Zhang H; Chen S; Zeng M; Lin D; Wang Y; Wen X; Xu C; Yang L; Fan X; Gong Y; Zhang H; Kong X
Cell Physiol Biochem; 2018; 49(5):1918-1932. PubMed ID: 30235451
[TBL] [Abstract][Full Text] [Related]
22. Silybin attenuates LPS-induced lung injury in mice by inhibiting NF-κB signaling and NLRP3 activation.
Zhang B; Wang B; Cao S; Wang Y; Wu D
Int J Mol Med; 2017 May; 39(5):1111-1118. PubMed ID: 28350048
[TBL] [Abstract][Full Text] [Related]
23. Baicalin exerts protective effects against lipopolysaccharide-induced acute lung injury by regulating the crosstalk between the CX3CL1-CX3CR1 axis and NF-κB pathway in CX3CL1-knockout mice.
Ding XM; Pan L; Wang Y; Xu QZ
Int J Mol Med; 2016 Mar; 37(3):703-15. PubMed ID: 26782291
[TBL] [Abstract][Full Text] [Related]
24. Cordycepin inhibits LPS-induced acute lung injury by inhibiting inflammation and oxidative stress.
Lei J; Wei Y; Song P; Li Y; Zhang T; Feng Q; Xu G
Eur J Pharmacol; 2018 Jan; 818():110-114. PubMed ID: 29054740
[TBL] [Abstract][Full Text] [Related]
25. Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice.
Chen X; Yang X; Liu T; Guan M; Feng X; Dong W; Chu X; Liu J; Tian X; Ci X; Li H; Wei J; Deng Y; Deng X; Chi G; Sun Z
Int Immunopharmacol; 2012 Oct; 14(2):209-16. PubMed ID: 22835426
[TBL] [Abstract][Full Text] [Related]
26. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
[TBL] [Abstract][Full Text] [Related]
27. Tenuigenin ameliorates acute lung injury by inhibiting NF-κB and MAPK signalling pathways.
Lv H; Zhu C; Liao Y; Gao Y; Lu G; Zhong W; Zheng Y; Chen W; Ci X
Respir Physiol Neurobiol; 2015 Sep; 216():43-51. PubMed ID: 25930113
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M
Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice.
San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N
Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of PKR ameliorates lipopolysaccharide-induced acute lung injury by suppressing NF-κB pathway in mice.
Li Y; Xiao J; Tan Y; Wang J; Zhang Y; Deng X; Luo Y
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):165-172. PubMed ID: 28511573
[TBL] [Abstract][Full Text] [Related]
31. Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice.
Zhou F; Zhang Y; Chen J; Hu X; Xu Y
Eur J Pharmacol; 2016 Nov; 791():735-740. PubMed ID: 27756605
[TBL] [Abstract][Full Text] [Related]
32. Corynoline attenuates LPS-induced acute lung injury in mice by activating Nrf2.
Liu Y; Song M; Zhu G; Xi X; Li K; Wu C; Huang L
Int Immunopharmacol; 2017 Jul; 48():96-101. PubMed ID: 28486213
[TBL] [Abstract][Full Text] [Related]
33. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
[TBL] [Abstract][Full Text] [Related]
34. Citral inhibits lipopolysaccharide-induced acute lung injury by activating PPAR-γ.
Shen Y; Sun Z; Guo X
Eur J Pharmacol; 2015 Jan; 747():45-51. PubMed ID: 25281205
[TBL] [Abstract][Full Text] [Related]
35. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
Feng G; Sun B; Li TZ
Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
[TBL] [Abstract][Full Text] [Related]
36. The therapeutic effects of Jaceosidin on lipopolysaccharide-induced acute lung injury in mice.
Huang XL; Wei XC; Guo LQ; Zhao L; Chen XH; Cui YD; Yuan J; Chen DF; Zhang J
J Pharmacol Sci; 2019 Jul; 140(3):228-235. PubMed ID: 31358372
[TBL] [Abstract][Full Text] [Related]
37. Timosaponin B-II inhibits lipopolysaccharide-induced acute lung toxicity via TLR/NF-κB pathway.
Zhang T; Wang J; Wang S; Ma C
Toxicol Mech Methods; 2015; 25(9):665-71. PubMed ID: 26540118
[TBL] [Abstract][Full Text] [Related]
38. Sesamin Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Inhibition of TLR4 Signaling Pathways.
Qiang L; Yuan J; Shouyin J; Yulin L; Libing J; Jian-An W
Inflammation; 2016 Feb; 39(1):467-472. PubMed ID: 26468152
[TBL] [Abstract][Full Text] [Related]
39. β-Patchoulene from patchouli oil protects against LPS-induced acute lung injury via suppressing NF-κB and activating Nrf2 pathways.
Chen XY; Dou YX; Luo DD; Zhang ZB; Li CL; Zeng HF; Su ZR; Xie JH; Lai XP; Li YC
Int Immunopharmacol; 2017 Sep; 50():270-278. PubMed ID: 28711783
[TBL] [Abstract][Full Text] [Related]
40. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-κB pathway.
Liu Y; Wu H; Nie YC; Chen JL; Su WW; Li PB
Int Immunopharmacol; 2011 Oct; 11(10):1606-12. PubMed ID: 21640201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
